HealthDay News 8月1日报道： 当拓扑替康（topotecan）被作为治疗卵巢癌标准的一线化疗药物的时候，一位德国研究人员报道拓扑替康并不能增加患者的生存率并认为不宜推荐使用。 紫杉醇及卡铂联合化疗被认为是当代治疗卵巢癌的标准方案，尽管研究表明这种方案治疗有效且毒副反应小，但肿瘤仍有较高的死亡及复发率，基于此背景拓扑替康被作为治疗卵巢癌标准的一线化疗药物就被提出来了。 Journal of the National Cancer Institute 8月2日报道1308例未经治疗过的卵巢癌患者接受了紫杉醇及卡铂联合化疗继之采取拓扑替康化疗或继续观察病情。 研究结果表明拓扑替康并不能提高患者生存率或无瘤生存率，反而会增加血液相关的毒性及感染。 研究者得出结论：拓扑替康不宜作为一线化疗药物治疗卵巢癌，紫杉醇加卡铂方案仍然是治疗晚期卵巢癌的标准方案。

第九届全国妇科肿瘤学术会议于2006年11月18日——11月20日在广西南宁市顺利召开。本次会议的主要议题是，讨论和修订《常见妇科肿瘤诊治指南》。 有520人参加了本次会议，其中相当一部分是当今中国妇科肿瘤学界的有声望或重要贡献的专家和学者。会议交流论文共480篇，其中大会交流48篇、书面交流432篇；外请专家演讲3人。会议分六个专题进行交流，即外阴、阴道癌专题，子宫颈癌专题，子宫体癌专题，卵巢癌专题，滋养细胞肿瘤专题，妇科恶性肿瘤化疗专题。 会议听取了全国六大妇科肿瘤中心工作汇报，并指出了目前存在的问题和今后努力的方向，包括临床随机研究工作开展尚存在不足，妇科肿瘤医师认证工作、会员会费交纳和肿瘤登记等三方面工作还有待加强和完善，以及中心内部和各中心之间需要更多的开展研究和协作。 会议指出，制定《常见妇科肿瘤诊治指南》的目的是为了帮助医生制定临床诊治决策，提高医生水平，改善治疗效果；有助于合理利用资源和病人选择，减少医患矛盾；《指南》是动态发展的，需要不断纳入新观念、新技术、新方法，并及时做出相应的修订；同时，《指南》的制定、实施、监督应有相应的组织管理和政策干预。 大会指出，希望更多的医师参与、使用和评价《指南》，以提高《指南》的依从性和可操作性。另一方也呼吁建立相应的鼓励、检查和奖惩机制。

第18届FIGO会议期间，本站对即将成为现任FIGO主席的Dorothy Shaw作了一个专访，访问是由同为international fellow来自于菲律宾大学的Lee Clark医生所做。 Interview with incoming FIGO President, Dr. Dorothy Shaw (Canada) Dr. Lee Clark: Good afternoon Dr. Shaw, I am Dr. Lee Clark from the University of the Philippines and I am doing this interview on behalf of China OBGYN.net. We know you have a very hectic schedule but we are very fortunate to have you come around. Just briefly, I'll do an introduction. This is Dr Dorothy Shaw, from the British Columbia Women's Hospital, Vancouver, Canada. She is a prolific author of several respected publications, and is a strong advocate of women’s and children's health. She is the incoming president of the International Federation of Gynecology and Obstetrics. Thank you very much for your kind indulgence for this short interview. （Shaw博士来自加拿大温哥华的British Columbia女子医院，曾发表了多篇著作，她非常关注和支持女性和儿童健康事业。在本次会议上，她发表了题为“女性医疗权利和千年发展目标（MDG）：促进合作，达成目标”的报告。） Doctor, we would just like to ask you about this very important position that you are going to have with the FIGO. What will be the platform of your term, if you can give us a little bit of a hint as regards to your advocacy and focus? （下午好，Shaw博士，您能简单谈谈作为下届FIGO主席，您将倡导或将关注的焦点吗？）

The planning and preparations of the 2006 Congress in Malaysia Dr. Valarie Guinto (Philippines) with Dr. Abdul Aziz Yahya (Malaysia) Dr. Valarie Guinto: Good afternoon, I am Dr. Valarie Guinto from the Philippines. I am representing China OBGYN.net. We are going to conduct an interview. We are very fortunate today to have with us the man credited for the success of the 18th FIGO 2006 World Congress. He is a very prominent obstetrician and gynecologist from the Gleneagles Intan Medical Center. He is the Chair of the Obstetrical and Gynecological Society of Malaysia, and the local organizing committee of the 18th FIGO 2006 World Congress. We have here Dr Abdul Aziz Yahya. Dr. Yahya, I know you are very prominent and very recognized in your field, particularly in gynecological oncology, but the topic of this interview will focus more on how this Congress was organized. Everybody is talking about how well this Congress is organized. Maybe you can describe to us the pains and tribulations, from conception to birth, of this very successful Congress. Dr Abdul Aziz Yahya: Well, that is going to be a long story, because I have to tell you that it has not been that easy. But the advantage I had was that I had very good supporting colleagues and family that understood this adventure that we started many, many years ago. I call it an adventure because when you start an adventure you do not really know what the outcome will be. We started in 1998 when we decided to bid for the Congress. When I mooted the idea, there were people in my own society, in their decision, who thought it was not such a good idea, especially when we were competing against renowned cities. I am not going to summarize and say what happened, but we worked very hard to win that bid. The support from the Malaysian government has been excellent and I was able to convince key ministries in Malaysia to support us in our bid. When we eventually we put our bid in Washington, DC there was a lot of background work that we did. We had been lobbying in the background. We sent our senior members all over the globe to speak to voters who would be attending the assembly to work for us. This was our modus operandi. I even wrote letters. I do not speak French or Spanish but I had some of my patients who are French and Spanish to translated letters for me. I faxed these over to the president of some of the Spanish speaking societies and some of the French speaking societies. So in that sense we did a lot of work. But the importance of planning is also indicated. What you see today, a very successful meeting, is that planning has been rather refined, we planned ahead. We tried to anticipate what sort of problems we would encounter, but despite all that, it cannot be perfect. Hosting a Congress of this size we cannot expect perfection but what we can expect is somewhere near that, with as few hiccups as possible. So far we have not done too badly. But the key point here is you need to have supporting members, friends and also family. I made a personal sacrifice, and this has taken a toll. When I embarked on this adventure in the year 2000, and I am sure you have heard this story I am not going to repeat it, but there was a day my firstborn, a daughter, was born. She was delivered by c-section at 9:00 in the morning and I had to kiss my wife goodbye, who was still in pain, at 3:00 pm, to be on the airplane. That was not a good thing a husband should do but we were committed. I was committed as a bidding chairman to actually win the bid for Malaysia, so a bit of personal sacrifice there. But we did it.

PC Ho教授来自于香港大学妇产科，他是本次第18届FIGO科学委员会的主席，对于FIGO整个议题的组织起了非常重要的作用。他同时也是本站的顾问委员会的成员。 在FIGO会议期间，我们有幸对他进行了一个简短的采访。 ​

最近，《中华妇产科杂志》编委会进行了改选，第十届编辑委员会成立，现公布名单如下： 顾 问： 刘庸 张丽珠 翁黎驹 田翠华 名誉总编辑： 曹泽毅 总 编 辑： 郎景和 副总编辑： 林其得 魏丽惠 沈 铿 黄醒华 何柏松（港） 孔北华 潘 伟#

中新社香港十一月十六日电(记者陈伊敏)香港防癌天使服务协会今日公布，世界上首个有效预防子宫颈癌的疫苗正式在香港推出。新疫苗不仅用于预防子宫颈癌，还能用于预防外阴及阴道的癌前病变。 　　防癌天使服务协会在新闻发布会上，公布子宫颈癌疫苗正式在香港推出，并为二十一岁和十岁的两位香港女孩注射了预防子宫颈癌第一针。据介绍，这种“四合一”混合疫苗 上个月获得香港药剂业及毒药管理局批准在港注册。 　　香港中文大学医学院妇产科学系名誉临床副教授张德康说，几乎所有子宫颈癌都是由“人类乳头瘤病毒”(HPV)引发的。常规医学推介的“柏氏抹片”(子宫颈癌细胞检查)能及早发现，但不能预防细胞变坏。该疫苗则能有效预防四种HPV(HPV6、11、16、18 )病毒的感染，从而达到预防癌症的效果。 　　中大医学院妇产科名誉临床助理教授卢永杰说，约百分之七十的子宫颈癌是由HPV16及HPV18两种人类乳头瘤病毒引起的。近五年来的研究表明，对于预防这两种病毒引致的宫颈癌，该疫苗的功效是百分之百。此外，该疫苗还能预防外阴道和阴道癌。 　　提到疫苗可能产生的副作用，卢永杰表示，并无副作用，如果有过敏性的副作用也是轻微、短暂的。因 ~~爲~~ 注入体内的是一个只含病毒蛋白的“空壳”，而不含病毒基因。因此新疫苗只会提高免疫力而不会致病。 　　卢永杰还强调，接受疫苗注射的女性应该继续定期做“柏氏抹片”检查，以预防其他HPV病毒所引发的子宫颈癌。 　　据悉，该疫苗目前已获四十三个国家和地区的批准。功效集中在九岁至二十六岁未有性行为的女性身上。每针价格一千五百港元，一年内分阶段接受三剂注射能确保产生体内免疫力。 　　子宫颈癌在全球女性最常见的癌症中居第二位，是导致女性癌症死亡的第二号杀手。估计全球每年约有近三十万人死于该癌症。

第一届中华医学会妇产科学分会绝经学组于2000年11月成立,为学组工作和绝经事业做出了卓有成效的贡献。现任期已满，经学组成员推荐、自荐以及各地方学会推荐，现组成第二届中华医学会妇产科学分会绝经学组成员，名单如下： 组长 郁 琦 北京协和医院妇产科 副组长 张绍芬 复旦大学附属妇产科医院 副组长 张淑兰 沈阳中国医科大学附二院妇产科

2006年12月1日～3日，在云南昆明举行了全国第2届绝经相关问题高级学术研讨会，在此前进行的中华医学会妇产科分会绝经学组第2届组委会的改选中，北京协和医院妇产科郁琦教授新当选为组长。会议上也就绝经相关的问题进行了讨论和规范的制订工作。

广泛和成功的大会选题 香港大学P.C. Ho教授专访 记者 北京协和医院妇产科 龚晓明 香港大学P.C. Ho教授是本届大会的科学委员会主席，他同时也是中国妇产科网编辑委员会的顾问，FIGO会议间，我们对他进行了专访。 记者：您作为大会科学委员会的主席，您会经常遇到很多文章的选择，这次大会的一个重要议题是如何降低孕妇的死亡率，您能简单谈谈为何选择这个议题吗？ Ho教授：在发展中国家，很多妇女在怀孕时会丧生，孕产妇死亡率很高，这引起了很多人的重视，所以我们认为很有必要讨论这个问题。 记者：我想这次会议您肯定收到了很多文章，请简单介绍关于这次会议收到的文章吗？ Ho教授：这次会议收到文章包括录像共有2300多篇，其中有1900多位自投稿，邀请的教授撰稿444篇。可以说从一开始反应就非常好，远远超出了我们的预期。